- Home
- LPCN vs ENZ Comparison
LPCN vs ENZ Comparison
Compare LPCN & ENZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LPCN
- ENZ
- Stock Information
- Founded
- LPCN 1997
- ENZ 1976
- Country
- LPCN United States
- ENZ United States
- Employees
- LPCN N/A
- ENZ N/A
- Industry
- LPCN Biotechnology: Pharmaceutical Preparations
- ENZ Medical Specialities
- Sector
- LPCN Health Care
- ENZ Health Care
- Exchange
- LPCN Nasdaq
- ENZ Nasdaq
- Market Cap
- LPCN 36.8M
- ENZ 37.9M
- IPO Year
- LPCN N/A
- ENZ N/A
- Fundamental
- Price
- LPCN $4.87
- ENZ $0.78
- Analyst Decision
- LPCN Strong Buy
- ENZ
- Analyst Count
- LPCN 1
- ENZ 0
- Target Price
- LPCN $10.00
- ENZ N/A
- AVG Volume (30 Days)
- LPCN 33.5K
- ENZ 235.0K
- Earning Date
- LPCN 11-07-2024
- ENZ 12-16-2024
- Dividend Yield
- LPCN N/A
- ENZ N/A
- EPS Growth
- LPCN N/A
- ENZ N/A
- EPS
- LPCN N/A
- ENZ N/A
- Revenue
- LPCN $7,922,926.00
- ENZ $30,314,000.00
- Revenue This Year
- LPCN N/A
- ENZ N/A
- Revenue Next Year
- LPCN N/A
- ENZ N/A
- P/E Ratio
- LPCN N/A
- ENZ N/A
- Revenue Growth
- LPCN N/A
- ENZ N/A
- 52 Week Low
- LPCN $2.44
- ENZ $0.68
- 52 Week High
- LPCN $11.79
- ENZ $1.50
- Technical
- Relative Strength Index (RSI)
- LPCN 47.54
- ENZ 28.67
- Support Level
- LPCN $4.68
- ENZ $0.68
- Resistance Level
- LPCN $5.28
- ENZ $1.05
- Average True Range (ATR)
- LPCN 0.36
- ENZ 0.06
- MACD
- LPCN -0.01
- ENZ -0.03
- Stochastic Oscillator
- LPCN 44.44
- ENZ 22.18
About LPCN Lipocine Inc.
Lipocine Inc is a clinical-stage biopharmaceutical company. It is focused on oral drug delivery technology for the development of pharmaceutical products focusing on metabolic and endocrine disorders. The company's product TLANDO is an oral testosterone replacement therapy ("TRT"). It also has other products in the pipeline such as LPCN 1144, LPCN 1148, and LPCN 1107. The Company has single reportable segment being, research and development for the delivery of drugs using its proprietary delivery technology.
About ENZ Enzo Biochem Inc. ($0.01 Par Value)
Enzo Biochem Inc is a bioscience company. The firm manufactures, develops and sell their proprietary solutions and platforms to clinical laboratories, specialty clinics and researchers and physicians internationally. The company has one reportable segment, Products, which focuses on labeling and detection technologies from DNA to whole cell analysis, including a comprehensive portfolio of thousands of high-quality products, including antibodies, genomic probes, assays, biochemicals, and proteins.